Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Rees

Showing results (1-10 of 175) with videos related to

Pageof 18
Sort By:
RSC Medicinal Chemistry|February 25, 2022
Medicines for millions of patientsDavid C Rees
Blood|February 11, 2021
Hydroxyurea: coming to conclusions on safetyDavid C Rees
Haematologica|April 2, 2011
The rationale for using hydroxycarbamide in the treatment of sickle cell diseaseDavid C Rees
Haematologica|September 1, 2022
The beginnings of molecular medicineDavid C Rees
The Lancet. Haematology|April 1, 2016
To begin at the beginning: sickle cell disease in AfricaDavid C Rees
The Indian Journal of Medical Research|November 16, 2021
Sickle cell disease: More than a century of progress. Where do we stand now?Valentine Brousse, David C Rees
Expert Opinion on Investigational Drugs|June 1, 2017
Prasugrel hydrochloride for the treatment of sickle cell diseaseNicola Conran, David C Rees
Expert Review of Hematology|August 2, 2011
The safety and efficacy of hydroxycarbamide in infants with sickle cell anemiaClare Wykes, David C Rees
Angewandte Chemie (International Ed. in English)|November 4, 2015
Opportunity Knocks: Organic Chemistry for Fragment-Based Drug Discovery (FBDD)Christopher W Murray, David C Rees
British Journal of Haematology|July 1, 2026
Methaemoglobinaemia: From pathophysiology to contemporary clinical managementAlexander J Twine, David C Rees
Pageof 18

Showing results (1-10 of 175) with videos related to

Sort By:
Pageof 18
RSC Medicinal Chemistry|February 25, 2022
Medicines for millions of patientsDavid C Rees
Blood|February 11, 2021
Hydroxyurea: coming to conclusions on safetyDavid C Rees
Haematologica|April 2, 2011
The rationale for using hydroxycarbamide in the treatment of sickle cell diseaseDavid C Rees
Haematologica|September 1, 2022
The beginnings of molecular medicineDavid C Rees
The Lancet. Haematology|April 1, 2016
To begin at the beginning: sickle cell disease in AfricaDavid C Rees
The Indian Journal of Medical Research|November 16, 2021
Sickle cell disease: More than a century of progress. Where do we stand now?Valentine Brousse, David C Rees
Expert Opinion on Investigational Drugs|June 1, 2017
Prasugrel hydrochloride for the treatment of sickle cell diseaseNicola Conran, David C Rees
Expert Review of Hematology|August 2, 2011
The safety and efficacy of hydroxycarbamide in infants with sickle cell anemiaClare Wykes, David C Rees
Angewandte Chemie (International Ed. in English)|November 4, 2015
Opportunity Knocks: Organic Chemistry for Fragment-Based Drug Discovery (FBDD)Christopher W Murray, David C Rees
British Journal of Haematology|July 1, 2026
Methaemoglobinaemia: From pathophysiology to contemporary clinical managementAlexander J Twine, David C Rees
Pageof 18